Colesevelam hydrochloride-ezetimibe combination lipid-lowering therapy in patients with diabetes or metabolic syndrome and a history of statin intolerance. [electronic resource]
Producer: 20070412Description: 11-6 p. digitalISSN:- 1934-2403
- Aged
- Allylamine -- administration & dosage
- Anticholesteremic Agents -- administration & dosage
- Azetidines -- administration & dosage
- Cholesterol, HDL -- blood
- Cholesterol, LDL -- blood
- Colesevelam Hydrochloride
- Diabetes Mellitus, Type 2 -- complications
- Drug Therapy, Combination
- Dyslipidemias -- drug therapy
- Ezetimibe
- Female
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- adverse effects
- Male
- Metabolic Syndrome -- complications
- Middle Aged
- Retrospective Studies
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.